The prevalence of obesity has been on the rise in recent years and the UAE will be among the top 10 countries with the highest obesity rates in the Eastern Mediterranean. According to the Obesity Atlas 2022, the prevalence of the disease in children is 26.72%, in teenagers 21.00%, and in men according to his BMI ≥ 30, BMI ≥ 35, BMI ≥ 40, from 37.01% 12.28% to 3.37%. In women, they are 49.82% to 23.12% to 9.24%, respectively1. These statistics clearly show that people in the United Arab Emirates are at risk of experiencing several ailments caused by obesity. , constantly reminding patients that it is a major health problem.
Obese people are at increased risk of many serious health conditions, including type 2 diabetes, heart disease, stroke, some cancers, and many other complications. Lifestyle changes, such as dietary adjustments and exercise, are the cornerstones of weight loss interventions, but these methods are not always effective for everyone and are often associated with significant and successful weight management. is not sufficient for
In recent years, there have been several drugs approved by the FDA for the treatment of obesity. One of the most promising new therapies are agents from the family of GLP-1 receptor analogues. GLP-1 RA drugs are a class of weight loss drugs that have been shown to be effective in weight loss. These drugs work by suppressing hunger signals and increasing the feeling of fullness.
They also appear to be generally safe and well tolerated. GLP-1 medications are prescribed as part of a holistic lifestyle intervention that includes individual coaching and support through diet, exercise, sleep, and emotional health education. This is done to allow members to make ongoing lifestyle changes. Metabolic health plays an important role in a person’s weight loss success.
Dr. Rita Nawar, Medical Director of WEMA Health
Medicinal weight loss solutions, when used in combination with a healthy diet and exercise, can help people suffering from obesity finally reach their weight loss goals and regain their health. That’s why we’ve helped them co-develop multi-dimensional solutions with leading medical experts.
WEMA Health is a virtual-first, medicated, end-to-end obesity program that helps members lose up to 20% of their body weight, connecting members with endocrinologists through an innovative, cutting-edge app. We focus on diet, exercise and psychosocial support by prescribing GLP-1 medications to our members.
For more information, please visit www.joinwema.com/en.
